Regulatory & Legal

Motive's new AI automates driver records and compliance, offering a powerful shield against millions in fines and crippling administrative paperwork.

New data on Spyre Therapeutics' SPY003 suggests a twice-yearly shot for IBD is possible, part of a broader strategy to challenge market giants.

A new partnership aims to secure the U.S. drone supply chain by manufacturing advanced, compliant battery systems for agricultural and defense applications.

New Directions Mental Health adds cutting-edge Spravato and TMS therapies, expanding access for Pennsylvanians with treatment-resistant depression.

With a clean security review, NatGold's plan to tokenize in-ground gold gains credibility, but can its ambitious vision reshape the future of money?

After facing credit downgrades and high debt, the specialty chemicals giant has struck a key deal with lenders and installed new leadership to forge a path to recovery.

Bausch + Lomb beats Q4 revenue forecasts, propelled by its blockbuster dry eye drug MIEBO, and issues a confident financial outlook for 2026.

A 106% rise in online luring and new AI tactics have experts urging parents to have safety talks with children before they ever go online.

Upwork announces a new $300M share buyback, signaling deep confidence in its AI strategy and financial health as it aims to redefine the future of work.

AI firm Docebo's $60M share buyback is complicated by its majority owner's surprise move and new debt, sparking questions about its strategy.

In a major step to prevent future health crises, the CDC has selected Cepheid to help create rapid diagnostic tests for emerging threats before they spread.

Hyliion's fuel-agnostic generator runs on diesel, meeting tough emission rules without add-ons and unlocking resilient power for defense and data centers.

Riding a wave of innovation and strategic shifts, the cruise wellness leader posts record earnings and projects over $1B in 2026 revenue.

A new biotech emerges with massive funding and a next-gen 'shuttle' to deliver safer, more effective Alzheimer's therapies directly to the brain.

The produce giant reported strong 2025 earnings after divesting its vegetable unit, reducing debt, and investing in new high-growth areas like avocado oil.

Polestar unveils a bold plan to launch four new models by 2028, but can the EV maker overcome financial hurdles and intense market competition?

Auddia Inc. announces a merger with its CEO's holdings, creating a new $250M entity, McCarthy Finney, and leaving current shareholders with a 20% stake.

A new report reveals retail traders are abandoning anonymous forums for platforms with audited data, professionalizing the meme stock era for good.

The specialty minerals giant reports solid Q4 earnings while announcing a major strategic shift away from industrial ventures to focus on high-growth areas.

The online gaming operator smashed 2025 expectations with record revenue and profits, signaling strong confidence in its casino-first and international strategy.